# Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease

> **NCT01602419** · — · COMPLETED · sponsor: **Octapharma** · enrollment: 120 (actual)

## Conditions studied

- Von Willebrand Disease

## Interventions

- **OTHER:** Patients using Wilate as standard of care

## Key facts

- **NCT ID:** NCT01602419
- **Lead sponsor:** Octapharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2021-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01602419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01602419, "Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01602419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*